Jacobs Levy Equity Management, Inc Eli Lilly & CO Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 16,272 shares of LLY stock, worth $12.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

16,272

Previous 20,881 22.07%

Holding current value

$12.8 Million

Previous $18.9 Million 23.75%

% of portfolio

0.06%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $3.56 Million - $4.42 Million	-4,609 Reduced 22.07%	16,272 $14.4 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $7.11 Million - $8.91 Million	9,807 Added 88.56%	20,881 $18.9 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $5.12 Million - $6.85 Million	8,651 Added 357.04%	11,074 $8.62 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.08 Million - $1.28 Million	-2,060 Reduced 45.95%	2,423 $1.41 Million
Q3 2023 Nov 16, 2023	BUY	$434.7 - $599.3 $1.95 Million - $2.69 Million	4,483 New	4,483 $2.41 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $30.9 Million - $36.3 Million	-99,526 Reduced 65.82%	51,687 $17.8 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $46.7 Million - $54.4 Million	145,112 Added 2378.5%	151,213 $55.3 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $1.81 Million - $2.06 Million	6,101 New	6,101 $1.97 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $33.4 Million - $43.2 Million	-203,078 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $20.4 Million - $27 Million	-156,197 Reduced 43.48%	203,078 $34.3 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $29.9 Million - $34.6 Million	-204,763 Reduced 36.3%	359,275 $53.2 Million
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $20.5 Million - $24.7 Million	150,202 Added 36.3%	564,038 $92.6 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $38.1 Million - $47.2 Million	320,315 Added 342.51%	413,836 $57.4 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $6.98 Million - $8.64 Million	65,268 Added 231.01%	93,521 $12.3 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.98 Million - $2.15 Million	-18,524 Reduced 39.6%	28,253 $3.16 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $36,560 - $42,675	-330 Reduced 0.7%	46,777 $5.18 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $7.68 Million - $9.04 Million	-68,962 Reduced 59.41%	47,107 $6.11 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $5.75 Million - $6.44 Million	-54,250 Reduced 31.85%	116,069 $13.4 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $27.2 Million - $34 Million	-317,230 Reduced 65.07%	170,319 $18.3 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $360,332 - $413,548	4,760 Added 0.99%	487,549 $41.6 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $20 Million - $23.6 Million	269,850 Added 126.73%	482,789 $37.4 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $8.98 Million - $9.63 Million	109,620 Added 106.1%	212,939 $18 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $14.9 Million - $16.5 Million	-192,981 Reduced 65.13%	103,319 $8.84 Million
Q2 2017 Nov 09, 2017	BUY	N/A	296,300	296,300 $24.4 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Eli Lilly & CO Transaction History